Impediments to Comparative Clinical Trials With Proton Therapy
Author:
- 1 May 2016
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 95 (1) , 4-8
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II–III inoperable non-small cell lung cancerRadiotherapy and Oncology, 2015
- Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancerCancer, 2011
- De Testimonio: on the evidence for decisions about the use of therapeutic interventionsClinical Medicine, 2008
- Progress in Evidence-Based MedicineJAMA, 2008
- Observational Research, Randomised Trials, and Two Views of Medical SciencePLOS Medicine, 2008
- Secondary neutrons in clinical proton radiotherapy: A charged issueRadiotherapy and Oncology, 2008
- Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: How do protons compare with other conformal techniques?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Cost‐effectiveness of proton radiation in the treatment of childhood medulloblastomaCancer, 2005
- A new system for grading recommendations in evidence based guidelinesBMJ, 2001
- Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research DesignsNew England Journal of Medicine, 2000